Jieling Chen

568 total citations
37 papers, 362 citations indexed

About

Jieling Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Jieling Chen has authored 37 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Jieling Chen's work include Diabetes Treatment and Management (14 papers), Diabetes Management and Research (13 papers) and Heart Failure Treatment and Management (4 papers). Jieling Chen is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diabetes Management and Research (13 papers) and Heart Failure Treatment and Management (4 papers). Jieling Chen collaborates with scholars based in United States, China and United Kingdom. Jieling Chen's co-authors include Cho Lee Wong, Vinay Mehta, Kimberly G. Brodovicz, Samuel S. Engel, Michael J. Davies, Larry Radican, Qiaoyi Zhang, Yang Bai, Huiyuan Li and Yuen Yu Chong and has published in prestigious journals such as Diabetes, Scientific Reports and American Journal of Preventive Medicine.

In The Last Decade

Jieling Chen

32 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jieling Chen United States 9 122 57 54 46 39 37 362
Bogdana Adriana Năsui Romania 12 79 0.6× 45 0.8× 46 0.9× 23 0.5× 34 0.9× 29 410
Gagan Priya India 9 128 1.0× 38 0.7× 36 0.7× 25 0.5× 50 1.3× 34 323
Alexis A Oetting United States 9 137 1.1× 115 2.0× 39 0.7× 23 0.5× 45 1.2× 19 399
Valentina Serrano Chile 11 167 1.4× 68 1.2× 38 0.7× 22 0.5× 60 1.5× 23 374
Vicente Renato Bagnoli Brazil 13 173 1.4× 45 0.8× 25 0.5× 34 0.7× 76 1.9× 57 585
Daniel J. Mazur United States 11 99 0.8× 90 1.6× 86 1.6× 24 0.5× 34 0.9× 25 518
Kai J. Bühling Germany 16 127 1.0× 74 1.3× 56 1.0× 31 0.7× 89 2.3× 38 810
Romina Fornes Sweden 18 69 0.6× 161 2.8× 73 1.4× 35 0.8× 61 1.6× 28 846
Mahnaz Shahnazi Iran 14 47 0.4× 56 1.0× 49 0.9× 38 0.8× 38 1.0× 49 516

Countries citing papers authored by Jieling Chen

Since Specialization
Citations

This map shows the geographic impact of Jieling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieling Chen more than expected).

Fields of papers citing papers by Jieling Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieling Chen. The network helps show where Jieling Chen may publish in the future.

Co-authorship network of co-authors of Jieling Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jieling Chen. A scholar is included among the top collaborators of Jieling Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieling Chen. Jieling Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McEwan, Phil, V. Foos, Geraint Roberts, et al.. (2025). Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model. Diabetes Obesity and Metabolism. 27(4). 1752–1761. 1 indexed citations
3.
Gao, Jiamin, Xianzhen Huang, Huawei He, et al.. (2024). Mtb/HIV co-infection immune microenvironment subpopulations heterogeneity. International Immunopharmacology. 143(Pt 1). 113341–113341. 1 indexed citations
4.
He, Peikun, Rong Z. Gan, Jieling Chen, et al.. (2024). Differential diagnosis value of sympathetic skin response and cutaneous silent period on early-stage multiple system atrophy and Parkinson disease. Parkinsonism & Related Disorders. 126. 107046–107046. 2 indexed citations
5.
Davis, Jason A., David T. Booth, Phil McEwan, et al.. (2024). Cost-Effectiveness of Dapagliflozin for Patients with Heart Failure Across the Spectrum of Ejection Fraction: A Pooled Analysis of DAPA-HF and DELIVER Data. European Journal of Heart Failure. 26(3). 664–673. 4 indexed citations
6.
McEwan, Phil, et al.. (2023). Estimating the value of sodium‐glucose cotransporter‐2 inhibitors within the context of contemporary guidelines and the totality of evidence. Diabetes Obesity and Metabolism. 25(7). 1830–1838. 7 indexed citations
7.
Huang, Bing, Fenfei Gao, Jieling Chen, et al.. (2023). Demyelination in the medial prefrontal cortex by withdrawal from chronic nicotine causes impaired cognitive memory. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 129. 110901–110901.
9.
Bai, Yang, Cho Lee Wong, Jieling Chen, & Winnie K.W. So. (2023). Implementing a tailored communication intervention to increase colonoscopy screening rates among first-degree relatives of people with colorectal cancer: Lessons learned. European Journal of Oncology Nursing. 67. 102408–102408. 2 indexed citations
10.
Li, Yanjun, et al.. (2023). Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma. Scientific Reports. 13(1). 18799–18799. 15 indexed citations
11.
Miller, Robert J.H., Derek S. Chew, Nowell M. Fine, et al.. (2023). Cost-Effectiveness of Immediate Initiation of Dapagliflozin in Patients with a History of Heart Failure. European Journal of Heart Failure. 25(2). 238–247. 3 indexed citations
12.
Booth, David T., Jason A. Davis, Phil McEwan, et al.. (2023). The Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: A European Health-Economic Analysis of the DELIVER Trial. European Journal of Heart Failure. 25(8). 1386–1395. 7 indexed citations
13.
Benedict, Ágnes, Emily R. Hankosky, Jieling Chen, et al.. (2022). A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes. PharmacoEconomics. 40(8). 743–750. 1 indexed citations
15.
Li, Huiyuan, et al.. (2021). Effects of Acceptance and Commitment Therapy on health-related outcomes for patients with advanced cancer: A systematic review. International Journal of Nursing Studies. 115. 103876–103876. 54 indexed citations
17.
Chen, Jieling, Magaly Perez‐Nieves, Erik Spaepen, et al.. (2020). An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany. Postgraduate Medicine. 132(8). 727–736.
18.
Zhang, Dangui, Jieling Chen, & William Ba‐Thein. (2018). Hand-foot-mouth disease and use of steroids, intravenous immunoglobulin, and traditional Chinese herbs in a tertiary hospital in Shantou, China. BMC Complementary and Alternative Medicine. 18(1). 190–190. 6 indexed citations
19.
Zhang, Yuhu, Jieling Chen, Rong Z. Gan, et al.. (2017). The patterns of EEG changes in early-onset Parkinson's disease patients. International Journal of Neuroscience. 127(11). 1028–1035. 15 indexed citations
20.
Du, Yongming, et al.. (2017). NS1 of H7N9 Influenza A Virus Induces NO-Mediated Cellular Senescence in Neuro2a Cells. Cellular Physiology and Biochemistry. 43(4). 1369–1380. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026